糖化血红蛋白与糖尿病患者腹壁疝修补术后不良结局无关:ACHQC研究
本研究基于ACHQC数据库回顾性纳入2167例接受择期腹壁疝修补术且HbA1c可用的成人糖尿病患者,按HbA1c<8%与≥8%分组比较。结果显示两组在30天并发症、伤口并发症、再手术、再入院、死亡率、住院时间及生活质量与疼痛评分上均无临床显著差异,回归分析未发现HbA1c与并发症、手术部位感染或复合复发存在关联。
要点
- 糖尿病患者择期腹壁疝修补术前HbA1c≥8%与30天不良结局无显著关联
- HbA1c水平与手术部位感染及复合复发风险无关
- 不应仅因HbA1c升高而推迟择期腹壁疝修补术
核心结论
- 在择期腹壁疝修补的糖尿病患者中,未发现HbA1c与手术结局存在关联的证据。
研究设计与样本
- 回顾性队列研究,使用Abdominal Core Health Quality Collaborative(ACHQC)数据库。
- 纳入2167例成人糖尿病患者,均接受择期腹壁疝修补且HbA1c结果可用,分为HbA1c<8%(1776例)与≥8%(391例)两组。
主要发现
- 两组中位年龄61岁,中位BMI 34 kg/m2,75%为ASA 3级。
- HbA1c<8%组中位HbA1c为6.5%,≥8%组为8.7%。
- 73%为切口疝,34%为复发疝,中位疝宽6 cm;63%采用开放入路,46%行肌筋膜松解。
- 中位随访27天,两组总体30天并发症、伤口并发症、再手术、再入院、死亡率、住院时间及生活质量与疼痛评分均无临床显著差异。
- 回归分析未发现HbA1c与并发症、手术部位感染或复合复发率存在关联。
临床怎么用
- 对于糖尿病患者,择期腹壁疝修补术前不必仅因HbA1c≥8%而推迟手术。
局限性
- 中位随访仅27天,无法评估长期结局。
- 为回顾性数据库研究,可能存在选择偏倚与未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Elevated preoperative glycated hemoglobin (HbA1c) is believed to predict complications in diabetic patients undergoing ventral hernia repair (VHR). Our objective was to assess the association between HbA1c and outcomes of VHR in diabetic patients. METHODS: We conducted a retrospective cohort study using the Abdominal Core Health Quality Collaborative (ACHQC) database. We included adult diabetic patients who underwent elective VHR with an available HbA1c result. The patients were divided into two groups (HbA1c < 8% and HbA1c ≥ 8%). Patient demographics, comorbidities, hernia characteristics, operative details, and surgical outcomes were compared. Multivariable logistic regression analysis of complications was performed. Cox proportional hazard regression was used to assess probability of composite recurrence at different HbA1c levels. RESULTS: 2167 patients met the inclusion criteria (HbA1c < 8% = 1,776 and HbA1c ≥ 8% = 391). Median age was 61 years and median body mass index was 34 kg/m2. 75% had an American Society of Anesthesiology class of 3. The median HbA1c was 6.5% in the HbA1c < 8% group versus 8.7% in the HbA1c ≥ 8% group. 73% were incisional hernias, 34% were recurrent, and median hernia width was 6 cm. Open approach was used in 63% and myofascial release was performed in 46%. Median follow-up was 27 days. There were no clinically significant differences in the rates of overall 30-day complications, wound complications, reoperation, readmission, mortality, length of stay and quality of life and pain scores between the two groups. Regression analyses did not identify an association between HbA1c and the rates of complications, surgical site infection or composite recurrence across the spectrum of HbA1c values. CONCLUSION: Our study finds no evidence of an association between HbA1c and operative outcomes in diabetic patients undergoing elective VHR.
引用
- Al-Mansour MR, Vargas M, Olson MA, et al. S-144 lack of association between glycated hemoglobin and adverse outcomes in diabetic patients undergoing ventral hernia repair: an ACHQC study. Surg Endosc. 2022. PMID: 35969297. doi:10.1007/s00464-022-09479-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。